Patient-reported pain and other quality of life domains as prognostic factors for survival in a phase III clinical trial of patients with advanced breast cancer
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Smyth, Emily Nash
Liepa, Astra M.
Funding for this research was provided by:
Eli Lilly and Company (US)